Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

Market Cap	13.38B
Revenue (ttm)	3.61B
Net Income (ttm)	748.99M
Shares Out	563.16M
EPS (ttm)	1.33
PE Ratio	17.89
Forward PE	16.05
Dividend	0.90 (3.83%)
Ex-Dividend Date	Jun 20, 2024

Volume	4,644,700
Average Volume	4,933,923
Open	23.50
Previous Close	23.48
Day's Range	23.45 - 23.84
52-Week Range	18.49 - 27.26
Beta	0.31
RSI	59.21
Earnings Date	Aug 13, 2025

About SHA:600285

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 2,435
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600285

Financial Performance

In 2024, SHA:600285's revenue was 3.50 billion, an increase of 5.72% compared to the previous year's 3.31 billion. Earnings were 722.55 million, an increase of 27.19%.